Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0R5XK
|
||||
Former ID |
DNC012014
|
||||
Drug Name |
ONO-1714
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Septic shock [ICD9: 785.52; ICD10:A41.9] | Discontinued in Phase 1 | [547187] | ||
Structure |
Download2D MOL |
||||
Formula |
C7H11ClN2
|
||||
Canonical SMILES |
CC1CC(=NC2C1C2Cl)N
|
||||
InChI |
1S/C7H11ClN2/c1-3-2-4(9)10-7-5(3)6(7)8/h3,5-7H,2H2,1H3,(H2,9,10)/t3-,5-,6+,7-/m0/s1
|
||||
InChIKey |
SEVICIFJHBFRBO-OIADKPKDSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Nitric oxide synthase, inducible | Target Info | Modulator | ||
BioCyc Pathway | Citrulline-nitric oxide cycle | ||||
KEGG Pathway | Arginine biosynthesis | ||||
Arginine and proline metabolism | |||||
Metabolic pathways | |||||
Calcium signaling pathway | |||||
HIF-1 signaling pathway | |||||
Peroxisome | |||||
Salmonella infection | |||||
Pertussis | |||||
Leishmaniasis | |||||
Chagas disease (American trypanosomiasis) | |||||
Toxoplasmosis | |||||
Amoebiasis | |||||
Tuberculosis | |||||
Pathways in cancer | |||||
Small cell lung cancer | |||||
NetPath Pathway | IL1 Signaling Pathway | ||||
IL2 Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.